Beatriz Llamus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beatriz llamus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beatriz Llamus Today - Breaking & Trending Today

EIT Health: Arthex Biotech closes €42M Series B financing round

EIT Health-supported start-up, Arthex Biotech, has successfully closed a €42 million Series B financing round. Prior to attracting these funds, the Valencia-based clinical-stage biotech start-up received an EIC accelerator grant, having been fast-tracked through our support. ....

Beatriz Llamus , European Innovation Council , Health Fast , Centre For The Development Of Industrial Technology , Arthex Biotech , Columbus Venture Partners , Hadean Ventures , Sound Bioventures , Invivo Capital , Adbio Partners , Industrial Technology , Myotonic Dystrophy Type , Fast Track ,

ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1)

/PRNewswire/ ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs. ....

France General , Jose Mesa , Beatriz Llamus , Amy Conrad , Company Contact , European Innovation Council , University Of Paris , Business School , Corporate Head Of Business Development Valneva , Centre For The Development Of Industrial Technology , Columbus Venture Partners , Hadean Ventures , Sound Bioventures , Invivo Capital , Adbio Partners , Industrial Technology , Myotonic Dystrophy Type , Chief Executive , Columbus Venture , Orphan Drug Designation , Executive Chairman , Chief Operating Officer , Vice President , Corporate Head , Business Development , Media Contact ,

Arthex announces regulatory milestones met in its program to develop ATX-01 in Myotonic Dystrophy Type 1

/PRNewswire/ Arthex Biotech S.A., a pre-clinical-stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high. ....

United States , Beatriz Llamus , Centre For The Development Of Industrial Technology , European Medicines Agency , Drug Administration , Myotonic Dystrophy Type , Investigational New Drug , Clinical Trial Application , Scientific Advice , Orphan Drug Designation , Chief Executive Officer , Orphan Drug , Arthex Biotech , Invivo Capital , Adbio Partners , Industrial Technology , Chief Executive ,

Arthex Biotech Appoints Frédéric Legros, Ph.D., as Executive Chairman of the Board

/PRNewswire/ Arthex Biotech S.A., a pre-clinical stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high. ....

France General , Beatriz Llamus , Company Board Of Directors As Executive Chairman , Corporate Head Of Business Development Valneva , Centre For The Development Of Industrial Technology , Business School , University Of Paris , Corporate Business Development , Business Development , Chief Operating Officer , Vice President , Corporate Head , Arthex Biotech , Executive Chairman , Invivo Capital , Adbio Partners , Industrial Technology , Chief Executive ,